Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli "Federico II", Via S. Pansini, 5, 80131, Naples, Italy.
TIGEM, Via Campi Flegrei 34, 80078, Pozzuoli, NA, Italy.
J Endocrinol Invest. 2018 Jun;41(6):711-717. doi: 10.1007/s40618-017-0795-7. Epub 2017 Nov 20.
Congenital hypothyroidism is a frequent disease occurring with an incidence of about 1/1500 newborns/year. In about 75% of the cases, CH is caused by alterations in thyroid morphogenesis, defined "thyroid dysgenesis" (TD). TD is generally a sporadic disease but in about 5% of the cases a genetic origin has been demonstrated. Previous studies indicate that Dnajc17 as a candidate modifier gene for hypothyroidism, since it is expressed in the thyroid bud, interacts with NKX2.1 and PAX8 and it has been associated to the hypothyroid phenotype in mice carrying a single Nkx2.1 and Pax8 genes (double heterozygous knock-out).
The work evaluates the possible involvement of DNAJC17 in the pathogenesis of TD.
High-resolution DNA melting analysis (HRM) and direct sequencing have been used to screen for mutations in the DNAJC17 coding sequence in 89 patients with TD.
Two mutations have been identified in the coding sequence of DNAJC17 gene, one in exon 5 (c.350A>C; rs79709714) and one in exon 9 (c.610G>C; rs117485355). The last one is a rare variant, while the rs79709714 is a polymorphism. Both are present in databases and the frequency of the alleles is not different between TD patients and controls.
DNAJC17 mutations are not frequently present in patients with TD.
先天性甲状腺功能减退症是一种常见疾病,发病率约为 1/1500 名新生儿/年。在大约 75%的病例中,CH 是由甲状腺形态发生的改变引起的,定义为“甲状腺发育不良”(TD)。TD 通常是一种散发性疾病,但在大约 5%的病例中,已经证明了遗传起源。先前的研究表明,Dnajc17 作为甲状腺功能减退症的候选修饰基因,因为它在甲状腺芽中表达,与 NKX2.1 和 PAX8 相互作用,并与携带单个 Nkx2.1 和 Pax8 基因(双杂合敲除)的小鼠的甲状腺功能减退表型相关。
本研究评估了 DNAJC17 基因在 TD 发病机制中的可能作用。
使用高分辨率 DNA 熔解分析(HRM)和直接测序技术对 89 例 TD 患者的 DNAJC17 编码序列进行突变筛查。
在 DNAJC17 基因的编码序列中发现了两个突变,一个在exon 5(c.350A>C;rs79709714),一个在 exon 9(c.610G>C;rs117485355)。后者是一种罕见的变异,而 rs79709714 是一种多态性。这两种变异都存在于数据库中,等位基因的频率在 TD 患者和对照组之间没有差异。
TD 患者中 DNAJC17 基因突变并不常见。